Peer Review reports
From: Ripasudil alleviated the inflammation of RPE cells by targeting the miR-136-5p/ROCK/NLRP3 pathway
| Original Submission | ||
|---|---|---|
| 23 Dec 2019 | Submitted | Original manuscript |
| 28 Jan 2020 | Reviewed | Reviewer Report - Alessandro Meduri |
| 8 Feb 2020 | Reviewed | Reviewer Report - Konstantina Riri |
| 23 Feb 2020 | Author responded | Author comments - Zhao Gao |
| 7 Mar 2020 | Reviewed | Reviewer Report - Alessandro Meduri |
| 18 Mar 2020 | Author responded | Author comments - Zhao Gao |
| Resubmission - Version 2 | ||
| 23 Feb 2020 | Submitted | Manuscript version 2 |
| Publishing | ||
| 23 Mar 2020 | Editorially accepted | |
| 6 Apr 2020 | Article published | 10.1186/s12886-020-01400-5 |
You can find further information about peer review here.